F8 and hemophilia A: Herein we investigated the potential effect of human IVIG co-injected with recombinant human FVIII (rFVIII) on the development of antibodies to FVIII in hemophilia A mice, hypothesizing that co-injection of FVIII together with IVIG will modulate anti-FVIII immune responses in hemophilia A mice.